Table 5.
Fortified SFY impact on relative organs weights and plasma biochemical profile of treated rats.
| Parameters | Units | G1 | G2 | G3 | G4 | G5 | G6 |
|---|---|---|---|---|---|---|---|
| Relative weight gain and organs weights | |||||||
| Weight gain | 13.51 ± 3.73b | 8.81 ± 2.32c | 14.42 ± 4.03b | 19.58 ± 1.56a | 15.79 ± 2.86ab | 14.37 ± 2.07b | |
| Liver | 3.53 ± 027a | 3.79 ± 0.55a | 4.23 ± 1.39a | 3.52 ± 0.32a | 3.71 ± 0.48a | 3.39 ± 0.37a | |
| Kidney | 0.63 ± 0.09a | 0.72 ± 0.23a | 0.84 ± 0.08a | 0.74 ± 0.08a | 0.76 ± 0.16a | 0.74 ± 0.06a | |
| Spleen | 0.52 ± 0.16a | 0.70 ± 0.20a | 0.88 ± 0.44a | 0.73 ± 0.11a | 0.83 ± 0.43a | 0.66 ± 0.14a | |
| Heart | 0.46 ± 0.01a | 0.46 ± 0.14a | 0.40 ± 0.04a | 0.38 ± 0.01a | 0.42 ± 0.03a | 0.36 ± 0.02a | |
| Lungs | 0.77 ± 0.03a | 0.84 ± 0.28a | 0.86 ± 0.14a | 0.78 ± 0.02a | 0.84 ± 0.33a | 0.82 ± 0.11a | |
| Plasma biochemical profile | |||||||
| Glucose | mg dL−1 | 203.25 ± 30.70a | 169.00 ± 31.60a | 187.75 ± 46.89a | 185.00 ± 38.56a | 192.50 ± 31.09a | 169.75 ± 20.96a |
| Plasma lipid profile | |||||||
| T.Ch. | mg dL−1 | 90.50 ± 7.89bc | 94.00 ± 12.19ab | 74.75 ± 7.93c | 88.25 ± 6.18bc | 89.75 ± 5.73bc | 108.75 ± 16.60a |
| TG | mg dL−1 | 182.25 ± 10.62a | 105.50 ± 9.88b | 76.50 ± 13.07b | 107.00 ± 16.43b | 99.50 ± 13.10b | 128.75 ± 75.07b |
| HDL | mg dL−1 | 32.00 ± 4.08c | 45.00 ± 5.35ab | 35.50 ± 7.85bc | 42.25 ± 8.05abc | 40.00 ± 3.36bc | 51.00 ± 9.76a |
| LDL | mg/dL−1 | 22.75 ± 3.30b | 29.25 ± 10.04ab | 27.75 ± 7.63ab | 28.25 ± 3.59ab | 29.25 ± 4.03ab | 33.75 ± 7.41a |
| Liver function | |||||||
| AST | IU L−1 | 195.5 ± 051.00a | 214.50 ± 48.23a | 176.75 ± 15.10a | 189.75 ± 31.60a | 170.50 ± 17.21a | 173.25 ± 26.98a |
| ALT | IU L−1 | 27.75 ± 5.12b | 41.75 ± 11.08a | 30.75 ± 3.20b | 42.00 ± 6.21a | 28.503.10b | 29.50 ± 2.08b |
| ALP | IU L−1 | 288.75 ± 23.94a | 287.50 ± 24.44a | 241.50 ± 27.04a | 262.25 ± 34.09a | 293.5 ± 42.16a | 264.25 ± 41.32a |
| T. Bilirubin | g dL−1 | 0.2175 ± 0.10a | 0.2325 ± 0.02a | 0.2075 ± 0.03a | 0.2275 ± 0.02a | 0.2850 ± 0.11a | 0.2350 ± 0.07a |
| Kidney function | |||||||
| Urea | mg dL−1 | 27.75 ± 3.59b | 37.00 ± 4.96a | 34.00 ± 3.36a | 26.50 ± 5.06b | 27.00 ± 1.82b | 27.75 ± 1.70b |
| Creatinine | μmol L−1 | 0.985 ± 0.08a | 0.970 ± 0.10a | 0.960 ± 0.07a | 0.983 ± 0.16a | 0.975 ± 0.17a | 0.983 ± 0.10a |
Data represented are means of relative weights (g) (n = 5) ±SD. Means in the same row followed by different letters are significantly different (p ≤ 0.05). A, G1 Negative control; B, G2 Positive control Group; C, G3 Fed SFY fortified with free Fe + ascorbic acid; D, G4 Fed SFY fortified with free Fe + FA + ascorbic acid; E, G5 Fed SFY fortified with Fe@ BSA-NPs + ascorbic acid; F, G6 Fed SFY fortified with Fe + FA@ BSA-NPs + ascorbic acid. BSA-NPs, Bovine Serum Albumin nanoparticles; FA, Folic Acid; T.Ch, Total cholesterol; TG, Triglycerides; HDL, High-density lipoprotein; LDL, Low-density lipoprotein; AST, Aspartate aminotransferase; ALT, Alanine aminotransferase; ALP, Alkaline phosphatase.